FDA Inspection 1158379 — Steven Sussman, MD

Steven Sussman, MD — FEI 3008206467

The FDA completed an inspection of Steven Sussman, MD on Nov 19, 2021 in Lawrenceville, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Nov 19, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Lawrenceville, NJ (United States)

Additional details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.